DE60306584D1 - Verwendung von einem 7-oxydierten DHEA Derivat zur Behandlung trockener Haut - Google Patents

Verwendung von einem 7-oxydierten DHEA Derivat zur Behandlung trockener Haut

Info

Publication number
DE60306584D1
DE60306584D1 DE60306584T DE60306584T DE60306584D1 DE 60306584 D1 DE60306584 D1 DE 60306584D1 DE 60306584 T DE60306584 T DE 60306584T DE 60306584 T DE60306584 T DE 60306584T DE 60306584 D1 DE60306584 D1 DE 60306584D1
Authority
DE
Germany
Prior art keywords
dry skin
oxidized
treatment
dhea derivative
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60306584T
Other languages
English (en)
Other versions
DE60306584T2 (de
Inventor
Gilles Rubinstenn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29415131&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60306584(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE60306584D1 publication Critical patent/DE60306584D1/de
Application granted granted Critical
Publication of DE60306584T2 publication Critical patent/DE60306584T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60306584T 2002-05-28 2003-04-18 Verwendung eines 7-oxidierten DHEA-Derivats zur Behandlung von trockener Haut Expired - Fee Related DE60306584T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0206504 2002-05-28
FR0206504A FR2840216B1 (fr) 2002-05-28 2002-05-28 Utilisation d'un derive 7-oxyde de la dhea pour le traitement des peaux seches

Publications (2)

Publication Number Publication Date
DE60306584D1 true DE60306584D1 (de) 2006-08-17
DE60306584T2 DE60306584T2 (de) 2007-06-28

Family

ID=29415131

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60306584T Expired - Fee Related DE60306584T2 (de) 2002-05-28 2003-04-18 Verwendung eines 7-oxidierten DHEA-Derivats zur Behandlung von trockener Haut

Country Status (6)

Country Link
EP (1) EP1366743B1 (de)
JP (1) JP2003342161A (de)
AT (1) ATE332122T1 (de)
DE (1) DE60306584T2 (de)
ES (1) ES2268293T3 (de)
FR (1) FR2840216B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4827433B2 (ja) * 2005-04-21 2011-11-30 株式会社 資生堂 水中油型乳化皮膚化粧料
US8758783B1 (en) 2012-12-20 2014-06-24 L'oreal Water-in-oil emulsion comprising pigments in the water phase
JP6371520B2 (ja) * 2013-12-26 2018-08-08 日本メナード化粧品株式会社 皮脂合成促進剤
FR3132220B1 (fr) 2022-01-31 2024-02-02 Oreal compositions cosmétiques perfectrices de peau et procédés d’utilisation
WO2023107199A1 (en) 2021-12-09 2023-06-15 L'oreal Skin perfecting cosmetic compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542129A (en) * 1982-08-16 1985-09-17 Norman Orentreich DHEA Formulations and methods for treating dry skin
FR2824737A1 (fr) * 2001-05-18 2002-11-22 Oreal Utilisations cosmetiques de la 3beta-acetoxy-7-oxo dhea
FR2826011B1 (fr) * 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique

Also Published As

Publication number Publication date
JP2003342161A (ja) 2003-12-03
FR2840216B1 (fr) 2006-02-03
DE60306584T2 (de) 2007-06-28
EP1366743B1 (de) 2006-07-05
ES2268293T3 (es) 2007-03-16
EP1366743A1 (de) 2003-12-03
ATE332122T1 (de) 2006-07-15
FR2840216A1 (fr) 2003-12-05

Similar Documents

Publication Publication Date Title
ATE468889T1 (de) Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
ATE552000T1 (de) Verwendung von isothiocyanat-verbindungen zur behandlung von prostata-erkrankungen und hautkrebs
DE502005001762D1 (de) Verwendung von N-Hydroxyalkyl-O-benzylchitosanen zur Haarbehandlung
DE60036169D1 (de) Methoden zur Behandlung der Hautpigmentierung
ATE486860T1 (de) Phenothiazin-derivat zur wundheilung
DE50312289D1 (de) Verfahren zur Isolierung von mesenchymalen Stammzellen des Haarfollikels
ATE492542T1 (de) Herstellung und anwendung von biphenyl-4-yl- carbonylaminosäurederivaten zur behandlung von obesitas
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
DE59909616D1 (de) Verfahren zur herstellung von luteolin und luteolin-derivaten
WO2006030439A3 (en) Compositions and methods for inducing hair growth
ATE198044T1 (de) Hydroperoxeicosatetraensäure derivate enthaltende zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
BRPI0410369A (pt) composições compreendendo uma amidina e um alcano poliol
DE60023816D1 (de) Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen
BR0312092A (pt) Uso de derivados de tio-oxindol no tratamento de distúrbios da pele
DE60021908D1 (de) Hydroxyeicosatetraenoatsalze, zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges
DE60231050D1 (de) Verwendung von Totarol zur Behandlung von Pruritus
DE60230961D1 (de) Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
DE60306584D1 (de) Verwendung von einem 7-oxydierten DHEA Derivat zur Behandlung trockener Haut
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE322244T1 (de) Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee